Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.56 USD | -0.13% | -3.84% | +11.46% |
04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.46% | 1.39B | |
+4.04% | 111B | |
+11.49% | 105B | |
-12.66% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.43% | 16.96B | |
+2.90% | 13.7B | |
+36.81% | 12.45B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Kiniksa Pharmaceuticals' Shares Rise as Q2 Net Income, Revenue Advance